Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Daily Top 10 COVID-19 publications

Deutsch | English | Español | Français | Italiano | Português; | Tiếng Việt | Türkçe


  Hepatitis

  Free Subscription


07.04.2020

2 Am J Gastroenterol
2 Arch Virol
1 BMC Cancer
1 Dig Dis Sci
1 Eur J Gastroenterol Hepatol
2 Gut
3 J Hepatol
1 J Med Virol
2 J Viral Hepat
1 MMWR Morb Mortal Wkly Rep
1 PLoS Pathog
2 Transplant Proc


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. HUANG CF, Lai HC, Chen CY, Tseng KC, et al
    Extrahepatic Malignancy Among Patients With Chronic Hepatitis C After Antiviral Therapy: A Real-World Nationwide Study on Taiwanese Chronic Hepatitis C Cohort (T-COACH).
    Am J Gastroenterol. 2020 Mar 26. doi: 10.14309/ajg.0000000000000606.
    PubMed         Abstract available

  2. KIDAMBI TD, Chu P, Lee JK, Lin JL, et al
    Immunotherapy-Associated Pseudomembranous Colitis.
    Am J Gastroenterol. 2019;114:1708.
    PubMed        


    Arch Virol

  3. LI Y, Shen C, Yang L, Yang Y, et al
    Intra-host diversity of hepatitis B virus during mother-to-child transmission: the X gene may play a key role in virus survival in children after transmission.
    Arch Virol. 2020 Apr 2. pii: 10.1007/s00705-020-04597.
    PubMed         Abstract available

  4. FITE RO, Kooti W, Azeze GA, Tesfaye B, et al
    Seroprevalence and factors associated with hepatitis B virus infection in blood donors in Ethiopia: a systematic review and meta-analysis.
    Arch Virol. 2020 Mar 26. pii: 10.1007/s00705-020-04591.
    PubMed         Abstract available


    BMC Cancer

  5. AL-AMERI AAM, Wei X, Lin L, Shao Z, et al
    Preoperative risk stratification for early recurrence of HBV-related hepatocellular carcinoma after deceased donor liver transplantation: a five-eight model development and validation.
    BMC Cancer. 2019;19:1136.
    PubMed         Abstract available


    Dig Dis Sci

  6. MUKHTAR NA, Evon DM, Yim C, Lok AS, et al
    Patient Knowledge, Beliefs and Barriers to Hepatitis B Care: Results of a Multicenter, Multiethnic Patient Survey.
    Dig Dis Sci. 2020 Apr 1. pii: 10.1007/s10620-020-06224.
    PubMed         Abstract available


    Eur J Gastroenterol Hepatol

  7. YU HC, Tseng JC, Lu LY, Hu JC, et al
    Monitoring by viral load and quantitative hepatitis B surface antigen in patients with hepatitis B virus infection receiving immunosuppressive therapy.
    Eur J Gastroenterol Hepatol. 2020 Mar 20. doi: 10.1097/MEG.0000000000001707.
    PubMed         Abstract available


    Gut

  8. SU F, Ioannou GN, Berry K
    No difference in hepatocellular carcinoma risk between chronic hepatitis B patients treated with entecavir versus tenofovir.
    Gut. 2020 Mar 30. pii: gutjnl-2019-319867. doi: 10.1136/gutjnl-2019-319867.
    PubMed         Abstract available

  9. HUTCHINSON SJ, Valerio H, McDonald SA, Yeung A, et al
    Population impact of direct-acting antiviral treatment on new presentations of hepatitis C-related decompensated cirrhosis: a national record-linkage study.
    Gut. 2020 Mar 26. pii: gutjnl-2019-320007. doi: 10.1136/gutjnl-2019-320007.
    PubMed         Abstract available


    J Hepatol

  10. VERNA EC, Morelli G, Terrault NA, Lok AS, et al
    DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort.
    J Hepatol. 2020 Mar 31. pii: S0168-8278(20)30193.
    PubMed         Abstract available

  11. SANGIOVANNI A, Alimenti E, Gattai R, Filomia R, et al
    Undefined/non-malignant hepatic nodules are associated with early occurrence of HCC in DAA-treated patients with HCV-related cirrhosis.
    J Hepatol. 2020 Mar 31. pii: S0168-8278(20)30192.
    PubMed         Abstract available

  12. BOON D, Bruce V, Patel EU, Quinn J, et al
    Antibody avidity-based approach to estimate population-level incidence of hepatitis C.
    J Hepatol. 2020 Mar 30. pii: S0168-8278(20)30190.
    PubMed         Abstract available


    J Med Virol

  13. JAMSHIDI S, Bokharaei-Salim F, Esghaei M, Bastani MN, et al
    Occult HCV and Occult HBV Co-infection in Iranian Human Immunodeficiency Virus-Infected Individuals.
    J Med Virol. 2020 Mar 31. doi: 10.1002/jmv.25808.
    PubMed         Abstract available


    J Viral Hepat

  14. TSENG CW, Wu SF, Chen CY, Ho YC, et al
    Characteristics of Regulatory T Cell Function in Patients with Chronic Hepatitis B and C Coinfection.
    J Viral Hepat. 2020 Apr 3. doi: 10.1111/jvh.13298.
    PubMed         Abstract available

  15. DESAI M, White E, Vora N, Gilson R, et al
    High incidence of Hepatitis C virus infection observed in the PROUD study of HIV pre-exposure prophylaxis.
    J Viral Hepat. 2020 Apr 3. doi: 10.1111/jvh.13297.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  16. BUSTAMANTE ND, Matyenyika SR, Miller LA, Goers M, et al
    Notes from the Field: Nationwide Hepatitis E Outbreak Concentrated in Informal Settlements - Namibia, 2017-2020.
    MMWR Morb Mortal Wkly Rep. 2020;69:355-357.
    PubMed        


    PLoS Pathog

  17. LUO J, Xi J, Gao L, Hu J, et al
    Role of Hepatitis B Virus Capsid Phosphorylation in Nucleocapsid Disassembly and Covalently Closed Circular DNA Formation.
    PLoS Pathog. 2020;16:e1008459.
    PubMed         Abstract available


    Transplant Proc

  18. CIECIURA T, Urbanowicz A, Foroncewicz B, Hryniewiecka E, et al
    Hepatocellular Carcinoma Is a Negative Predictor of Sustained Viral Response in Liver Transplant Recipients With Hepatitis C Treated With Direct-Acting Antivirals.
    Transplant Proc. 2020 Mar 30. pii: S0041-1345(19)31659.
    PubMed         Abstract available

  19. CIECIURA T, Hryniewiecka E, Foroncewicz B, Strzelczyk Z, et al
    Long-Term Follow-up of Liver Transplant Recipients Treated With Direct-Acting Antiviral Agents for Hepatitis C Recurrence After Transplantation.
    Transplant Proc. 2020 Mar 30. pii: S0041-1345(19)31656.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: